Li Luocheng, Wang Zhiwei, Hu Xiaoping, Wan Ting, Wu Hongbing, Jiang Wanli, Hu Rui
Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Biochem Biophys Res Commun. 2016 Oct 14;479(2):343-350. doi: 10.1016/j.bbrc.2016.09.078. Epub 2016 Sep 16.
Dysregulation of autophagy in endothelial cells plays a vital role in cardiovascular dysfunction and atherosclerosis. Accumulating evidence shows that miRNAs regulate autophagy in various cell types by targeting autophagy-related genes. In the present study, we found that a co-culture of human umbilical vein endothelial cells (HUVECs) with human aortic smooth muscle cells (HAoSMCs) inhibited autophagy activity in HUVECs. Furthermore, we isolated exosomes secreted by HAoSMCs, and confirmed that the exosomes contain miR-221/222. We investigated the role of miR-221/222 transferred by HAoSMC-derived exosomes in HUVECs. These exosomes induced an increase of miR-221/222 expression and a down-regulation of phosphatase and tensin homolog deleted on chromosome ten (PTEN) in HUVECs. Dual luciferase reporter assays revealed that miR-221/222 could bind to the 3'UTR of PTEN, which implied that PTEN was a direct target of miR-221/222. The expression of PTEN could be down-regulated by miR-221/222 over-expression. Then, we detected the expression of PTEN, LC3, ATG5, SQSTM1/p62, Beclin-1, Akt, and phospho-Akt in HUVECs transfected with miR-221/222 mimics and inhibitors. Our results demonstrated that miR-221/222 overexpression inhibited the expression of PTEN and subsequently activated Akt signaling, and eventually down-regulated the expression of LC3II, ATG5 and Beclin-1, and elevated the expression of SQSTM1/p62. This phenomenon can be reversed by the transfection of miR-221/222 inhibitors. These data suggested that miR-221/222 from HAoSMC-derived exosomes inhibited autophagy in HUVECs by modulating PTEN/Akt signaling pathway.
内皮细胞自噬失调在心血管功能障碍和动脉粥样硬化中起着至关重要的作用。越来越多的证据表明,微小RNA(miRNA)通过靶向自噬相关基因来调节多种细胞类型中的自噬。在本研究中,我们发现人脐静脉内皮细胞(HUVECs)与人主动脉平滑肌细胞(HAoSMCs)共培养会抑制HUVECs中的自噬活性。此外,我们分离了HAoSMCs分泌的外泌体,并证实这些外泌体含有miR-221/222。我们研究了HAoSMC来源的外泌体转移的miR-221/222在HUVECs中的作用。这些外泌体诱导HUVECs中miR-221/222表达增加以及第10号染色体缺失的磷酸酶和张力蛋白同源物(PTEN)表达下调。双荧光素酶报告基因检测显示,miR-221/222可与PTEN的3'非翻译区(3'UTR)结合,这表明PTEN是miR-221/222的直接靶点。miR-221/222过表达可下调PTEN的表达。然后,我们检测了用miR-221/222模拟物和抑制剂转染的HUVECs中PTEN、微管相关蛋白轻链3(LC3)、自噬相关蛋白5(ATG5)、p62/sequestosome-1(SQSTM1/p62)、Beclin-1、蛋白激酶B(Akt)和磷酸化Akt的表达。我们的结果表明,miR-221/222过表达抑制PTEN的表达,随后激活Akt信号通路,并最终下调LC3II、ATG5和Beclin-1的表达,上调SQSTM1/p62的表达。这种现象可通过转染miR-221/222抑制剂来逆转。这些数据表明,HAoSMC来源的外泌体中的miR-221/222通过调节PTEN/Akt信号通路抑制HUVECs中的自噬。